Vascular extension of pheochromocytoma is extremely rare but highly resectable. The aim of this study was to review the available information in the literature for patients with this condition.
Methods
A systematic literature search produced individual data for 29 treated patients with vascular extension of pheochromocytoma mainly to the inferior vena cava.
Results
Out of 29 reported cases, 26 have been treated surgically. Nine of these patients required cardiopulmonary bypass. Two patients died untreated and one patient declined surgical treatment and discharged to follow-up. In 24 patients including nine with primarily missed diagnosis, surgery was documented as curative.
Conclusion
Surgeons need to be aware of this extremely rare characteristic feature of pheochromocytoma and indicated medical work-up in order to properly diagnose and manage this challenging group of patients.
ChenHSippelRSO'DorisioMS. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma and medullary thyroid cancer. Pancreas2010; 39: 775–783.
4.
SingerJKochCAKassahunWT. A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis. Nat Rev Endocrinol2011; 7: 749–755.
5.
McNeilARBlokBHKoelmeyerTD. Pheochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust NZ J Med2000; 30: 648–652.
6.
GeelhoedGWDunnickNRDoppmanJL. Management of intravenous extension of endocrine tumors and prognosis after surgical treatment. Am J Surg1980; 139: 844–848.
7.
YoungJDJrQureshiASConnorTB. Problem lesions in adrenal surgery. J Urol1969; 101: 233–240.
8.
RoteARFlintLDEllisFH. Intracaval recurrence of pheochromocytoma extending into right atrium. New Engl J Med1977; 296: 1269–1271.
9.
KandpalHSharmaRGamangattiS. Imaging the inferior vena cava: a road less travelled. Radiographics2008; 28: 669–689.
10.
LauTNGoddardPVaidayaM. Involvement of the inferior vena cava by adrenal pheochromocytoma – MRI findings. Br J Radiol1997; 70: 303–305.
11.
DunnickNRDoppmanJLGeelhoedGW. Intravenous extension of endocrine tumors. AJR1980; 135: 471–476.
12.
DavisP. Malignant pheochromocytoma with functioning metastases. Lancet1955; 20: 52–56.
13.
MelicowMM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976. Cancer1977; 40: 1987–2004.
14.
CastelloPMelvinECRobertAK. Problems in the diagnosis of adrenal tumors. Radiology1977; 125: 335–341.
SmithEJMcPhersonGADLynnJ. Inferior vena cava involvement by a pheochromocytoma. Br J Surg1987; 74: 597.
20.
LevineEdeVriesPWetzelLH. MR imaging of inferior vena caval recurrence of extraadrenal pheochromocytoma. J Comput Assist Tomogr1987; 4: 717–718.
21.
FischerEWKellherJPPengellyAW. Invasion of the inferior vena cava in malignant pheochromocytoma. Br J Urol1988; 62: 272–273.
22.
ConceptionRSKochMOMcDougalWS. Management of primary nonrenal parenchymal malignancies with vena caval thrombus. J Urol1991; 145: 243–247.
23.
DunnCWSnyderWHRingWS. Pheochromocytoma with extension in to the inferior vena cava: a case report. Surgery1992; 111: 472–474.
24.
WoodsMSMullinsJRShellitoJL. Recommendations concerning the operative approach for pheochromocytoma invading the inferior vena cava. Surgery1994; 115: 771–775.
25.
SilvaMBJrSilvaHCSandagerGP. Prosthetic replacement of the inferior vena cava after resection of a pheochromocytoma. J Vasc Surg1994; 19: 169–173.
26.
RötkerJOberpenningFScheldHH. Pheochromocytomas with extension in to central vascular structures. Ann Thorac Surg1996; 61: 222–224.
27.
McLigeyoSOOliechJSRanaFS. Renal vein and intracaval invasion by an adrenal pheochromocytoma with extension into the right atrium: a case study. Afr J Health Sci1996; 3: 60–63.
28.
LuconAMJuniorRFPraxedesJN. Multicentric pheochromocytoma and involvement of the inferior vena cava. Sao Paulo Med J/Rev Paul Med2001; 119: 86–88.
29.
KikumoriTImaiTKanekoT. Intracaval endovascular ultrasonography for large adrenal and retroperitoneal tumors. Surgery2003; 134: 989–994.
30.
DossettLARudzinskiERBlevinsLS. Malignant pheochromocytoma of the organ of Zuckerkandl requiring aortic and vena caval reconstruction. Endocr Pract2007; 13: 493–497.
31.
DuralCBilgeOTokerA. Malignant pheochromocytoma with cavoaortal extension: transcaval removal of tumor without cardiopulmonary bypass. Minerv Chir2010; 65: 485–488.
32.
Motta-RamirezGARemerEMHertsBR. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. Am J Roentgenol2005; 185: 684–688.
33.
SkinnerDGPrichettTRLieskowskiG. Vena caval involvement by renal cell carcinoma. Ann Surg1989; 210: 387–392.
34.
McGavackTHBenjaminJWSpeerFD. Malignant pheochromocytoma of the adrenal medulla (paraganglioma): report of a case simulating carcinoma of adrenal cortex with secondary adrenal insufficieny. J Clin Endocr1942; 2: 332–338.
35.
DeLllisRALloydRVHeitzPU. Tumors of endocrine organs, Lyon: IARC Press, 2004.
36.
JamesREBakerHLScanlonPW. The roentgenological aspects of metastatic pheochromocytoma. Am J Roentgenol1972; 115: 783–793.
37.
BlakeMAKalraMKMaherMM. Pheochromocytoma: an imaging chameleon. Radiographics2004; 24(Suppl 1): S87–S99.
38.
ShenWTSturgeonCClarkOH. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery2004; 136: 1129–1137.
39.
GaoBSunYLiuZ. A logistic regression model for predicting malignant pheochromocytomas. J Cancer Res Clin Oncol2008; 134: 631–634.
40.
StrongVEKennedyTAl-AhmadieH. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery2008; 143: 759–768.
41.
GoldsteinREO'NeillJAHolcombGW. Clinical experience over 48 years with pheochromocytoma. Ann Surg1999; 229: 755–766.
42.
EisenhoferGGoldsteinDSWaltherMM. Biochemical diagnosis of pheochromocytoma: how to distinguish true from false-positive test results. J Clin Endocrinol Metab2003; 88: 2656–2666.
McLeanKLilienfeldHCaraccioloJT. Management of isolated adrenal lesions in cancer patients. Cancer Control2011; 18: 113–126.
45.
PacakKGoldsteinDSDoppmanJL. A “pheo” lurks: novel approaches for locating occult pheochromocytoma. J Clin Endocrinol Metab2001; 86: 3641–3646.
46.
Van WayCWIIIScottHWJrPageDL. Pheochromocytoma. Curr Prob Surg1974, pp. 1–59. June.
47.
RemineWHChongGCvan HeerdenJA. Current management of pheochromocytoma. Ann Surg1974; 179: 740–748.
48.
ShethSFishmanEK. Imaging of the inferior vena cava with MDCT. AJR2007; 189: 1243–1251.
49.
CuevasCRaskeMBushWH. Imaging primary and secondary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging. Curr Probl Diagn Radiol2006; 35: 90–101.
50.
ShulkinBLThompsonNWShapiroB. Pheochromocytomas: imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET. Radiology1999; 212: 35–41.
51.
BhatiaKSRezenkeRH. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal pheochromocytomas. CT and MRI correlation. Clin Endocrinol (oxf)2008; 69: 181–188.
52.
JacobsonAFDengHLombardJ. 123I-metaiodobenzylguanidine scintigraphy for the detection of neuroblastoma and Pheochromocytoma: results of meta-analysis. J Clin Endocrinol Metab2010; 95: 2596–2606.
53.
GroganRHMitmakerEJDuhQY. Changing paradigms in the treatment of malignant pheochromocytoma. Cancer Control2011; 18: 104–112.
